114 related articles for article (PubMed ID: 6127884)
1. Metabolic effects of prenalterol in healthy volunteers.
Klein G; Wirtzfeld A; Schmidt G; Zilker T
Acta Med Scand Suppl; 1982; 659():137-46. PubMed ID: 6127884
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of prenalterol in diabetic patients.
Oltmanns D
Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of prenalterol in healthy subjects.
Johnsson G
Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
[TBL] [Abstract][Full Text] [Related]
5. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
Rönn O; Johnsson G; Lundborg P
J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
[TBL] [Abstract][Full Text] [Related]
6. Effect of prenalterol in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic comparison between prenalterol and dobutamine.
Wester HA; Oltmanns D
Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
9. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
10. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
Andersson T; Heath A; Mattsson H
Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
[No Abstract] [Full Text] [Related]
11. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
12. Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist.
Irie Y; Igawa T; Hosokawa T; Saitoh Y
Eur J Pharmacol; 1979 Feb; 53(4):351-8. PubMed ID: 33812
[TBL] [Abstract][Full Text] [Related]
13. Practolol inhibition of some salbutamol-induced metabolic and hormonal responses.
Massara F; Martina V; Fassio V; Sapelli S; Molinatti G
Acta Diabetol Lat; 1977; 14(5-6):257-62. PubMed ID: 207065
[TBL] [Abstract][Full Text] [Related]
14. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
15. Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.
Svendsen TL; Hartling OJ; Trap-Jensen J
Eur J Clin Pharmacol; 1980 Oct; 18(3):219-23. PubMed ID: 6108219
[TBL] [Abstract][Full Text] [Related]
16. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
17. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
[TBL] [Abstract][Full Text] [Related]
18. Compartment model of prenalterol.
Klein G; Wirtzfeld A; Bozler G; Rönn O; Graffner C
Acta Med Scand Suppl; 1982; 659():99-107. PubMed ID: 6127903
[TBL] [Abstract][Full Text] [Related]
19. Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat.
Inamasu M; Totsuka T; Morita T; Takeyama S
Biochem Pharmacol; 1984 Jul; 33(14):2171-7. PubMed ID: 6147139
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
